Rolling CSO Model- Bioliance

---

The traditional CSO was built for Big Pharma's economics — not for a small company's first specialty, oncology or rare-disease launch.

Multi-year lock-ins. High SG&A baked into every fee. All-or-nothing headcount. It stacks maximum cost and maximum risk on you at the exact moment you can least afford either.

The Rolling CSO is the better way. Build a team fit to purpose and roll people in as territories become ready or profitable:

🔹 Align cost with value — pay for expertise, not overhead 🔹 Align risk with readiness — scale as the market proves out 🔹 Keep control — convert roles to your own headcount when you're ready

You add cost only against proven opportunity. That's not just a cheaper CSO — it's a smarter launch.

Most launch teams don't fall short on talent. They fall short because readiness was assumed instead of built.

That's the principle behind how we approach commercial readiness at Bioliance — a structured, technology-enabled program that takes a new field team from product knowledge to genuine customer credibility, with proof at every step.

Three things we've found matter most:

Two phases, not one push. Engagement readiness comes first: disease state fluency, product command, compliant messaging. Case and account readiness follows. Trying to do both at once produces reps who are half-ready at everything.

Three gates, not one test. What they know. What they say. And whether it still holds up a month into the field. That last gate is the one most programs skip — and the one that best predicts performance.

Reusable infrastructure, not a one-time event. Modules, certifications, and materials built to outlast turnover and onboard the next wave.

Readiness is built, not assumed.

Fractional leadership shouldn't feel like a stopgap.

At Bioliance Life Science Partners, we place experienced commercial operators — not generalist consultants — inside emerging and small life-science companies exactly where the gap is. Sales leadership, market access, regulatory, medical affairs, compliance, training and development, and more. Fractional or full-time.

Why it works:

→ Continuity when it matters most — through transitions, searches, and M&A, the business keeps moving. → Sized to the moment — senior capability without the fixed cost of a permanent hire. → Technology-driven — Cingo.AI and Cingo Pulse CRM put data behind every commercial decision.

We're built for specialty, rare disease, and oncology — the therapeutic areas where execution is hardest.

Bridging the crossroads of innovation and humanity.

bioliance.com

#LifeSciences #FractionalLeadership #Commercialization #Biotech #ProductLaunch

 Bioliance is revolutionizing Virtual Sales. Reimagining how companies can reach more prescribers cost effectively. Our Virtual Awareness Offer puts trained, science-literate representatives in front of HCPs and their staff with compliant, scripted messaging — all AI-powered by Cingo Pulse CRM, with built-in telephony, fax/email document dissemination, and real-time reporting. Programs launch in ~30 days at roughly $10 per contact, with every interaction captured and reported weekly. Read the white paper to see how it works. #LifeSciences #PharmaMarketing #HCPEngagement #AI 

Hiring commercial talent in life sciences isn't like hiring anywhere else — yet most staffing models treat it the same, screening for keywords instead of the ability to carry a complex therapy to market. At Bioliance Talent Solutions, we built a different model. Every search is led by operators and subject-matter experts who have carried a bag, built teams, and owned a number — so we only present candidates we'd hire onto our own teams. We pair that operator-led judgment with AI-powered sourcing across the industry's top platforms to move fast without trading quality for speed, then stand behind the result with guaranteed placements and transparent pricing. From executives and sales professionals to MSLs and marketing leaders across specialty, oncology, and rare disease, we place the people who move therapies forward. That's commercial talent, done the way it should be.